Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
Current Portion of Long-Term Debt Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
Current Portion of Long-Term Debt
CHf1.2m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Current Portion of Long-Term Debt
$1.5m
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Current Portion of Long-Term Debt
CHf687k
CAGR 3-Years
5%
CAGR 5-Years
0%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Current Portion of Long-Term Debt
CHf0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Current Portion of Long-Term Debt
CHf605k
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
1.2m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's Current Portion of Long-Term Debt amounts to 1.2m CHF.

What is Molecular Partners AG's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-1%

Over the last year, the Current Portion of Long-Term Debt growth was 1%. The average annual Current Portion of Long-Term Debt growth rates for Molecular Partners AG have been 1% over the past three years , -1% over the past five years .

Back to Top